Dr. Adam Benjafield is vice president of medical affairs at ResMed and convener of its academia-industry research collaboration medXcloud, as well as coauthor of the ALASKA study. He’s led more than 150 clinical studies ranging from product development and efficacy to international multicenter randomized controlled trials. He holds a bachelor’s and Ph.D. in medicine from the University of Sydney.